These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22100502)

  • 1. PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.
    Tsunemi T; La Spada AR
    Prog Neurobiol; 2012 May; 97(2):142-51. PubMed ID: 22100502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
    Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR
    Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC-1alpha, a new therapeutic target in Huntington's disease?
    McGill JK; Beal MF
    Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
    Cui L; Jeong H; Borovecki F; Parkhurst CN; Tanese N; Krainc D
    Cell; 2006 Oct; 127(1):59-69. PubMed ID: 17018277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired PGC-1alpha function in muscle in Huntington's disease.
    Chaturvedi RK; Adhihetty P; Shukla S; Hennessy T; Calingasan N; Yang L; Starkov A; Kiaei M; Cannella M; Sassone J; Ciammola A; Squitieri F; Beal MF
    Hum Mol Genet; 2009 Aug; 18(16):3048-65. PubMed ID: 19460884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1α, mitochondrial dysfunction, and Huntington's disease.
    Johri A; Chandra A; Flint Beal M
    Free Radic Biol Med; 2013 Sep; 62():37-46. PubMed ID: 23602910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
    Róna-Vörös K; Weydt P
    Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter.
    Martin E; Betuing S; Pagès C; Cambon K; Auregan G; Deglon N; Roze E; Caboche J
    Hum Mol Genet; 2011 Jun; 20(12):2422-34. PubMed ID: 21493629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.
    Chaturvedi RK; Calingasan NY; Yang L; Hennessey T; Johri A; Beal MF
    Hum Mol Genet; 2010 Aug; 19(16):3190-205. PubMed ID: 20529956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.
    Ju TC; Lin YS; Chern Y
    Cell Mol Life Sci; 2012 Dec; 69(24):4107-20. PubMed ID: 22627493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases.
    Zhang Q; Lei YH; Zhou JP; Hou YY; Wan Z; Wang HL; Meng H
    Neurochem Res; 2019 Sep; 44(9):2031-2043. PubMed ID: 31410709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.
    Tsunemi T; Ashe TD; Morrison BE; Soriano KR; Au J; Roque RA; Lazarowski ER; Damian VA; Masliah E; La Spada AR
    Sci Transl Med; 2012 Jul; 4(142):142ra97. PubMed ID: 22786682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.
    McMeekin LJ; Li Y; Fox SN; Rowe GC; Crossman DK; Day JJ; Li Y; Detloff PJ; Cowell RM
    J Neurosci; 2018 Mar; 38(13):3273-3286. PubMed ID: 29491012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.
    McConoughey SJ; Basso M; Niatsetskaya ZV; Sleiman SF; Smirnova NA; Langley BC; Mahishi L; Cooper AJ; Antonyak MA; Cerione RA; Li B; Starkov A; Chaturvedi RK; Beal MF; Coppola G; Geschwind DH; Ryu H; Xia L; Iismaa SE; Pallos J; Pasternack R; Hils M; Fan J; Raymond LA; Marsh JL; Thompson LM; Ratan RR
    EMBO Mol Med; 2010 Sep; 2(9):349-70. PubMed ID: 20665636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
    Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
    Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.
    Török R; Kónya JA; Zádori D; Veres G; Szalárdy L; Vécsei L; Klivényi P
    Cell Mol Neurobiol; 2015 Mar; 35(2):293-301. PubMed ID: 25319408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
    Zheng B; Liao Z; Locascio JJ; Lesniak KA; Roderick SS; Watt ML; Eklund AC; Zhang-James Y; Kim PD; Hauser MA; Grünblatt E; Moran LB; Mandel SA; Riederer P; Miller RM; Federoff HJ; Wüllner U; Papapetropoulos S; Youdim MB; Cantuti-Castelvetri I; Young AB; Vance JM; Davis RL; Hedreen JC; Adler CH; Beach TG; Graeber MB; Middleton FA; Rochet JC; Scherzer CR;
    Sci Transl Med; 2010 Oct; 2(52):52ra73. PubMed ID: 20926834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.
    Yang YN; Zhang MQ; Yu FL; Han B; Bao MY; Yan-He ; Li X; Zhang Y
    Biochem Pharmacol; 2023 Sep; 215():115717. PubMed ID: 37516277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells.
    Cowell RM; Talati P; Blake KR; Meador-Woodruff JH; Russell JW
    Biochem Biophys Res Commun; 2009 Feb; 379(2):578-82. PubMed ID: 19118529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease.
    Pacelli C; De Rasmo D; Signorile A; Grattagliano I; di Tullio G; D'Orazio A; Nico B; Comi GP; Ronchi D; Ferranini E; Pirolo D; Seibel P; Schubert S; Gaballo A; Villani G; Cocco T
    Biochim Biophys Acta; 2011 Aug; 1812(8):1041-53. PubMed ID: 21215313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.